NYSE: MBACM3 Brigade Acquisition Ii Corp Stock
$10.25+0.05 (+0.49%)
Updated Jun 2, 2023
MBAC Price
$10.25
Fair Value Price
N/A
Market Cap
$149.00M
52 Week Low
$9.44
52 Week High
$10.56
P/E
48.81x
P/B
-7.61x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$10.44M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.06
Operating Cash Flow
-$2B
Beta
0
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MBAC Overview
M3-Brigade Acquisition II Corporation is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the renewable energy sector. M3-Brigade Acquisition II was incorporated in 2020 and is headquartered in New York, NY.
Zen Score
–
Industry Average (7)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MBAC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MBAC was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MBAC is good value based on its earnings relative to its share price (48.81x), compared to the US market average (52.69x)
P/E vs Market Valuation
MBAC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more MBAC due diligence checks available for Premium users.
Be the first to know about important MBAC news, forecast changes, insider trades & much more!
MBAC News
Valuation
MBAC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
48.81x
Industry
42.23x
Market
52.69x
MBAC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MBAC is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
MBAC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-7.61x
Industry
-27.45x
MBAC's financial health
Profit margin
Revenue
$0.0
Net Income
$1.2M
Profit Margin
0%
MBAC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$47.5M
Liabilities
$20.7M
Debt to equity
-1.06
MBAC's short-term liabilities ($5.25M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MBAC's long-term liabilities ($15.47M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MBAC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MBAC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$519.8k
Investing
$361.1M
Financing
-$360.1M
MBAC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
MBAC vs Shell Company Stocks
M3 Brigade Acquisition Ii Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.